Biomerica Inc (BMRA)

$2.66 -0.04 (-1.48%)
Market Cap 7.96M
Revenue (ttm) 5.31M
Net Income (ttm) -4.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -93.60%
Debt to Equity Ratio 0.00
Volume 35,700
Avg Vol 157,192
Day's Range N/A - N/A
Shares Out 2.95M
Stochastic %K 73%
Beta 0.06
Analysts Strong Buy
Price Target $13.00

Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 645 2111
Fax: 949 553 1231
Address:
17571 Von Karman Avenue, Irvine, United States
BillionerOfKing
BillionerOfKing Dec. 27 at 3:28 AM
$BMRA Current Stock Price: $2.73
0 · Reply
ALLBulls_Blitz
ALLBulls_Blitz Dec. 26 at 9:20 PM
$$RZLV quirky as hell... Looking up Stayed heavy with $BMRA also, fkrs got to pop soon. see yall next week Lets go to the gym punish my legs, and shoulders Finish up at the pub Godspeed
0 · Reply
shuffle13
shuffle13 Dec. 26 at 8:54 PM
$IVP this thing has such a bullish look to it...top is ivp...bottom is $BMRA ...see what it did shortly after the 5 print
0 · Reply
FirewallV3
FirewallV3 Dec. 26 at 4:53 PM
$BMRA Conditions are shifting toward markets rewarding operational proof over narrative ambition. Forecast discipline should become more precise and conservative. Demonstrated durability would lengthen investor time horizons. Stronger outcomes appear only when priorities stay focused.
0 · Reply
www_larval_com
www_larval_com Dec. 23 at 8:52 PM
$AFJK 11%[47%] $FJET -4%[-59%] $BMRA 3%[8%] most notable movement into the final minutes of trading.
0 · Reply
GapUp103
GapUp103 Dec. 23 at 3:47 PM
$BMRA
0 · Reply
RidingUptrends
RidingUptrends Dec. 23 at 3:34 PM
If you like getting in them before the massive moves.. Drop @MomentumZeus a FOLLOW below. He's been calling some insane runners lately.. 🚀 $BENF $BMRA $ADGM are gaining
0 · Reply
topstockalerts
topstockalerts Dec. 23 at 3:29 PM
$BMRA It wants to move higher..
0 · Reply
OleNorway
OleNorway Dec. 23 at 3:06 PM
$BMRA 👀👀👀👀
0 · Reply
HFTB
HFTB Dec. 23 at 3:04 PM
$BMRA It was reasonable to wonder why on earth an $8.0 Billion mkt cap company like Henry Schein devoted resources to signing a marketing services agreement with little BMRA in October. It makes a lot more sense now with today's legitimately bullish CMS news, and here's to H. Schein's large national salesforce getting docs up and running with inFoods tests.
0 · Reply
Latest News on BMRA
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Dec 23, 2025, 8:19 AM EST - 6 days ago

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test

Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio

Dec 11, 2025, 8:08 AM EST - 18 days ago

Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio

Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Nov 25, 2025, 8:19 AM EST - 4 weeks ago

Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Nov 6, 2025, 8:19 AM EST - 7 weeks ago

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Oct 16, 2025, 8:19 AM EDT - 2 months ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica's inFoods® IBS Test in the U.S.

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Oct 15, 2025, 9:27 AM EDT - 2 months ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Oct 8, 2025, 8:19 AM EDT - 2 months ago

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

Sep 9, 2025, 8:08 AM EDT - 3 months ago

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Sep 3, 2025, 8:19 AM EDT - 4 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Test for Home Use

Biomerica Reports Fiscal 2025 Year End Results

Aug 29, 2025, 5:12 PM EDT - 4 months ago

Biomerica Reports Fiscal 2025 Year End Results

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

Aug 14, 2025, 8:19 AM EDT - 4 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Home Use

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Jul 2, 2025, 8:08 AM EDT - 6 months ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Jun 26, 2025, 8:19 AM EDT - 6 months ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Jun 6, 2025, 9:30 AM EDT - 7 months ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Jun 5, 2025, 8:19 AM EDT - 7 months ago

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

May 22, 2025, 8:19 AM EDT - 7 months ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

May 7, 2025, 8:19 AM EDT - 8 months ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

Apr 23, 2025, 8:19 AM EDT - 8 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Apr 17, 2025, 8:19 AM EDT - 9 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Biomerica Announces Reverse Stock Split

Apr 16, 2025, 9:00 AM EDT - 9 months ago

Biomerica Announces Reverse Stock Split

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Feb 26, 2025, 8:19 AM EST - 10 months ago

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Feb 19, 2025, 8:19 AM EST - 11 months ago

Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

Jan 16, 2025, 10:49 AM EST - 1 year ago

Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Jan 16, 2025, 8:19 AM EST - 1 year ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Jan 15, 2025, 8:19 AM EST - 1 year ago

Biomerica Reports Second Quarter Fiscal 2025 Financial Results

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nov 21, 2024, 8:19 AM EST - 1 year ago

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Nov 7, 2024, 9:09 AM EST - 1 year ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Oct 30, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Biomerica Reports First Quarter Fiscal 2025 Financial Results

Oct 16, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports First Quarter Fiscal 2025 Financial Results

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Sep 4, 2024, 8:19 AM EDT - 1 year ago

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

Biomerica Reports Fiscal 2024 Year End Results

Aug 29, 2024, 9:00 AM EDT - 1 year ago

Biomerica Reports Fiscal 2024 Year End Results

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Jul 1, 2024, 7:47 AM EDT - 1 year ago

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

May 13, 2024, 8:19 AM EDT - 1 year ago

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Apr 29, 2024, 8:19 AM EDT - 1 year ago

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

Biomerica provides update on inFoods® IBS expansion

Apr 15, 2024, 7:47 AM EDT - 1 year ago

Biomerica provides update on inFoods® IBS expansion

Biomerica Reports Third Quarter 2024 Financial Results

Apr 12, 2024, 7:23 PM EDT - 1 year ago

Biomerica Reports Third Quarter 2024 Financial Results

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Mar 28, 2024, 8:19 AM EDT - 1 year ago

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Feb 21, 2024, 8:19 AM EST - 2 years ago

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Jan 23, 2024, 8:19 AM EST - 2 years ago

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Biomerica Reports Second Quarter 2024 Financial Results

Jan 16, 2024, 8:19 AM EST - 2 years ago

Biomerica Reports Second Quarter 2024 Financial Results

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Dec 18, 2023, 7:47 AM EST - 2 years ago

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Nov 10, 2023, 8:19 AM EST - 2 years ago

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Nov 8, 2023, 8:19 AM EST - 2 years ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 1:10 PM EDT - 2 years ago

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

Biomerica Reports First Quarter 2024 Financial Results

Oct 13, 2023, 6:39 AM EDT - 2 years ago

Biomerica Reports First Quarter 2024 Financial Results

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Sep 26, 2023, 8:19 AM EDT - 2 years ago

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect™ Colorectal Disease Screening Test

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Aug 28, 2023, 8:19 AM EDT - 2 years ago

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

Biomerica Reports Fiscal 2023 Year End Results

Aug 25, 2023, 5:00 PM EDT - 2 years ago

Biomerica Reports Fiscal 2023 Year End Results

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Aug 3, 2023, 8:19 AM EDT - 2 years ago

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Disease Screening Test

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

Jun 21, 2023, 8:19 AM EDT - 2 years ago

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

BillionerOfKing
BillionerOfKing Dec. 27 at 3:28 AM
$BMRA Current Stock Price: $2.73
0 · Reply
ALLBulls_Blitz
ALLBulls_Blitz Dec. 26 at 9:20 PM
$$RZLV quirky as hell... Looking up Stayed heavy with $BMRA also, fkrs got to pop soon. see yall next week Lets go to the gym punish my legs, and shoulders Finish up at the pub Godspeed
0 · Reply
shuffle13
shuffle13 Dec. 26 at 8:54 PM
$IVP this thing has such a bullish look to it...top is ivp...bottom is $BMRA ...see what it did shortly after the 5 print
0 · Reply
FirewallV3
FirewallV3 Dec. 26 at 4:53 PM
$BMRA Conditions are shifting toward markets rewarding operational proof over narrative ambition. Forecast discipline should become more precise and conservative. Demonstrated durability would lengthen investor time horizons. Stronger outcomes appear only when priorities stay focused.
0 · Reply
www_larval_com
www_larval_com Dec. 23 at 8:52 PM
$AFJK 11%[47%] $FJET -4%[-59%] $BMRA 3%[8%] most notable movement into the final minutes of trading.
0 · Reply
GapUp103
GapUp103 Dec. 23 at 3:47 PM
$BMRA
0 · Reply
RidingUptrends
RidingUptrends Dec. 23 at 3:34 PM
If you like getting in them before the massive moves.. Drop @MomentumZeus a FOLLOW below. He's been calling some insane runners lately.. 🚀 $BENF $BMRA $ADGM are gaining
0 · Reply
topstockalerts
topstockalerts Dec. 23 at 3:29 PM
$BMRA It wants to move higher..
0 · Reply
OleNorway
OleNorway Dec. 23 at 3:06 PM
$BMRA 👀👀👀👀
0 · Reply
HFTB
HFTB Dec. 23 at 3:04 PM
$BMRA It was reasonable to wonder why on earth an $8.0 Billion mkt cap company like Henry Schein devoted resources to signing a marketing services agreement with little BMRA in October. It makes a lot more sense now with today's legitimately bullish CMS news, and here's to H. Schein's large national salesforce getting docs up and running with inFoods tests.
0 · Reply
www_larval_com
www_larval_com Dec. 23 at 3:02 PM
Dumbo reporting in! $BMRA just shot 5% higher to 14% (~2Mv) a moment ago, follow for more volatility.
0 · Reply
Lrzzz
Lrzzz Dec. 23 at 2:27 PM
$BMRA coiling... waiting for volume
0 · Reply
kebrik
kebrik Dec. 23 at 2:14 PM
Today's movers: $HIHO, $TRIB, $VIVK, $PCLA, and $BMRA
1 · Reply
Xvool
Xvool Dec. 23 at 2:10 PM
$BMRA 🚨Huge news 🚨300$ a test x 30 Million possible patients suffering from IBS = ($90 Billion in potential sales) 👉🚨🚨 Only 7 million market cap !! 👉🚨🚨 2.6 million float !! Irritable bowel syndrome affects approximately 10% to 15% of adults in the United States, representing over 30 million potential patients Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
0 · Reply
ildamiano1
ildamiano1 Dec. 23 at 2:05 PM
$BMRA This is actual big news - the USD300 subsidy will make this test free to take for anyone with any sort of decent health insurance policy. Huge positive revenue catalyst. Actually good to see it not go bananas pre-market - this news is value-enhancing in a major way.
0 · Reply
Stock_Catcher
Stock_Catcher Dec. 23 at 1:55 PM
$TRIB Posted right at start $1 almost 100 % gapper $HIHO posted near start ran again almost 100% gapper $BMRA $BBLG $MAMO all gapped 15%-60% , if you want trade ideas even earlier and help on price action using my experience link to join... everyday I find plays 💎 https://www.youtube.com/@StockCatcher/join
1 · Reply
WarriorSTC
WarriorSTC Dec. 23 at 1:51 PM
$BMRA Bullish view The company secured a significant commercial partnership with Henry Schein for U.S. marketing of inFoods IBS, published compelling clinical trial data in Gastroenterology showing effectiveness, and reported real-world data demonstrating a 49% reduction in IBS symptoms. The product has received a PLA code and features an innovative AI-powered Trigger Food Navigator.
0 · Reply
WarriorSTC
WarriorSTC Dec. 23 at 1:47 PM
$BMRA Bullish view https://www.stocktitan.net/news/BMRA/biomerica-announces-cms-medicare-payment-rate-of-300-for-pnqhjuhd5fxx.html
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 23 at 1:39 PM
$BMRA (+2.5% pre) Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test https://ooc.bz/l/88250
0 · Reply
DaBullRunner
DaBullRunner Dec. 23 at 1:35 PM
$MAMO BOOM!!!! 🚨TOVX🚨is my next one $AGQ $HIHO $TRIB $BMRA what a morning
0 · Reply
AlertsAndNews
AlertsAndNews Dec. 23 at 1:29 PM
$BMRA some hits on this Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
0 · Reply
Hurtadogoalkeeper
Hurtadogoalkeeper Dec. 23 at 1:24 PM
$BMRA https://investors.biomerica.com/news/news-details/2025/Biomerica-Announces-CMS-Medicare-Payment-Rate-of-300-for-Revolutionary-inFoods-IBS-Test/default.aspx
0 · Reply